NIH-funded research R01 grant

How fat cells communicate to control inflammation and insulin sensitivity

Official title: Adipocyte cytokine signaling as a coordinator of adipose tissue function

Funded at Lsu Pennington Biomedical Research Ctr · NIH-10811230 · Data updated 2026-11-12

This study is looking at how a substance called oncostatin M, made by immune cells in fat tissue, influences inflammation and insulin sensitivity in people with obesity, with the goal of finding new ways to help manage obesity-related health issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLsu Pennington Biomedical Research Ctr
NIH-funded
Lab location1 site (Baton Rouge, United States)
Project startJuly 15, 2024
Project endJune 30, 2028
Funding year2024
Award (this year)$350,000
NIH project number1R01DK134469-01A1
Project IDNIH-10811230 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are obese and experiencing insulin resistance or related metabolic disorders.

Less likely to help

Patients who are not obese or do not have metabolic disorders may not benefit from this research.

What this research studies

This research investigates the role of adipocyte (fat cell) signaling in regulating inflammation and insulin sensitivity in the context of obesity. It focuses on a specific cytokine called oncostatin M (OSM), which is produced by immune cells in adipose tissue. The study aims to understand how OSM signaling affects adipocyte function and inflammation, potentially leading to better management of obesity-related conditions. By exploring the mechanisms of adipocyte regulation, the research seeks to uncover new therapeutic targets for improving metabolic health.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve insulin sensitivity and reduce inflammation in obese patients.

How similar studies have gone: Previous research has shown promising results in understanding cytokine signaling in adipose tissue, suggesting that this approach could lead to significant advancements in obesity treatment.

Where this research is happening

  • Lsu Pennington Biomedical Research Ctr
    Baton Rouge, United States
    Active

Researchers

  • Principal investigator: Elks, Carrie M — Lsu Pennington Biomedical Research Ctr
  • Study coordinator: Elks, Carrie M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.